조영제 과민반응 관리의 실제: 국내 일개 대학병원 원내 관리지침 소개
Management of hypersensitivity reactions to contrast media
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
As imaging technologies have become essential for diagnosing various diseases, the use of contrast agents is rapidly expanding. As a result, hypersensitivity reactions (HSRs) to contrast agents have also increased. However, protocols for managing, diagnosing, and preventing these reactions are not fully established yet. Since the guidelines for contrast agent hypersensitivity suggested by domestic and international academic societies are not standardized and sometimes difficult to follow in medical facilities, there is a need for practical recommendations in a real-world setting. This review introduces the strategy to manage, diagnose, and prevent HSRs to contrast agents, which have been successfully implemented at Seoul National University Hospital for a decade. First, every single HSRs should be documented in the medical records because a previous history of hypersensitivity to contrast agents is the most significant risk factor for developing HSR to iodinated contrast media. Secondly, avoidance of culprit agents is the main strategy for preventing recurrences of HSRs to contrast agents. Thirdly, it is important to identify nonsensitized contrast agents using skin tests for future exposure to contrast media. In addition to skin testing, side chains of iodinated contrast media may provide a clue to reactive contrast agents. Fourthly, provocation tests can be performed in selected cases with a nonreactive agent based on the skin testing and side chain commonness. Prior to performing imaging studies, premedication can be applied stratified to the severity of the index HSR. All of these procedures are safe and prove to be executable in the medical facilities.
Abstract
As imaging technologies have become essential for diagnosing various diseases, the use of contrast agents is rapidly expanding. As a result, hypersensitivity reactions (HSRs) to contrast agents have also increased. However, protocols for managing, diagnosing, and preventing these reactions are not fully established yet. Since the guidelines for contrast agent hypersensitivity suggested by domestic and international academic societies are not standardized and sometimes difficult to follow in medical facilities, there is a need for practical recommendations in a real-world setting. This review introduces the strategy to manage, diagnose, and prevent HSRs to contrast agents, which have been successfully implemented at Seoul National University Hospital for a decade. First, every single HSRs should be documented in the medical records because a previous history of hypersensitivity to contrast agents is the most significant risk factor for developing HSR to iodinated contrast media. Secondly, avoidance of culprit agents is the main strategy for preventing recurrences of HSRs to contrast agents. Thirdly, it is important to identify nonsensitized contrast agents using skin tests for future exposure to contrast media. In addition to skin testing, side chains of iodinated contrast media may provide a clue to reactive contrast agents. Fourthly, provocation tests can be performed in selected cases with a nonreactive agent based on the skin testing and side chain commonness. Prior to performing imaging studies, premedication can be applied stratified to the severity of the index HSR. All of these procedures are safe and prove to be executable in the medical facilities.
참고문헌 (35)
- Trend analysis of reporting drug safety information, "Ministry of Food and Drug Safety", Ministry of Food and Drug Safety, ~ (2019)
- 김수정, "약물 아나필락시스: 의약품부작용보고원시자료 분석 연구", Allergy Asthma & Respiratory Disease, 8(1), pp.1~2 (2020), 대한 소아알레르기 호흡기학회
- 조민경, "요오드화 조영제 과민반응에 대한 임상 대처 최신 지견", Allergy Asthma & Respiratory Disease, 8(3), pp.107~113 (2020), 대한 소아알레르기 호흡기학회[DOI]
- Lerondeau B, "Analysis of cross-reactivity among radiocontrast media in 97 hypersensitivity reactions", J Allergy Clin Immunol, 137, pp.633~635 (2016)
- Brockow K, "Management of hypersensitivity reactions to iodinated contrast media", Allergy, 60, pp.150~158 (2005)
- Hosoya T, "Delayed adverse reactions to iodinated contrast media and their risk factors", Radiat Med, 18, pp.39~45 (2000)
- Brown SG, "Clinical features and severity grading of anaphylaxis", J Allergy Clin Immunol, 114, pp.371~376 (2004)
- Kim TH, "Biphasic and protracted anaphylaxis to iodinated contrast media", Eur Radiol, 28, pp.1242~1252 (2018)
- Lee SY, "Incidence and risk factors of immediate hypersensitivity reactions associated with low-osmolar iodinated contrast media : a longitudinal study based on a real-time monitoring system", J Investig Allergol Clin Immunol, 29, pp.444~450 (2019)
- Cha MJ, "Hypersensitivity reactions to iodinated contrast media : a multicenter study of 196 081 patients", Radiology, 293, pp.117~124 (2019)
- Chung SJ, "HLA-DRB1*15 : 02 is associated with iodinated contrast media-related anaphylaxis", Invest Radiol, 55, pp.304~309 (2020)
- Coop CA, "Are ACE inhibitors and beta-blockers dangerous in patients at risk for anaphylaxis?", J Allergy Clin Immunol Pract, 5, pp.1207~1211 (2017)
- Lee SY, "Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients", Ann Allergy Asthma Immunol, 118, pp.339~344 (2017)
- Park SJ, "Immediate mild reactions to CT with iodinated contrast media : strategy of contrast media readministration without corticosteroids", Radiology, 288, pp.710~716 (2018)
- Park HJ, "Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions : a multicentre retrospective cohort study", Eur Radiol, 27, pp.2886~2893 (2017)
- Kim SH, "Clinical value of radiocontrast media skin tests as a prescreening and diagnostic tool in hypersensitivity reactions", Ann Allergy Asthma Immunol, 110, pp.258~262 (2013)
- Sohn KH, "Finding the optimal alternative for immediate hypersensitivity to low-osmolar iodinated contrast", Invest Radiol, 56, pp.480~485 (2021)
- Schrijvers R, "Skin testing for suspected iodinated contrast media hypersensitivity", J Allergy Clin Immunol Pract, 6, pp.1246~1254 (2018)
- Ahn KM, "Validation of practical pathway in patients with anaphylaxis to low osmolar contrast media : a retrospective cohort study", J Allergy Clin Immunol Pract, 10, pp.2685~2692 (2022)
- Jung JW, "Outcomes of corticosteroid prophylaxis for hypersensitivity reactions to low osmolar contrast media in high-risk patients", Ann Allergy Asthma Immunol, 117, pp.304~309 (2016)
- Lasser EC, "Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material", N Engl J Med, 317, pp.845~849 (1987)
- Park SJ, "Corticosteroid prophylaxis may be not required for patients with mild hypersensitivity reaction to low-osmolar contrast media", Eur J Radiol, 130, pp.109152~ (2020)
- Mervak BM, "Intravenous corticosteroid premedication administered 5 hours before CT compared with a traditional 13-hour oral regimen", Radiology, 285, pp.425~433 (2017)
- Skidgel RA, "Goodman & Gilman’s: the pharmacological basis of therapeutics" (2015), McGraw-Hill Education
- Kang DY, "Incidence and risk factors of late adverse reactions to low-osmolar contrast media : a prospective observational study of 10, 540 exposures", Eur J Radiol, 146, pp.110101~ (2022)
- Yoon SH, "Skin tests in patients with hypersensitivity reaction to iodinated contrast media : a meta-analysis", Allergy, 70, pp.625~637 (2015)
- Kim SR, "Intradermal testing with radiocontrast media to prevent recurrent adverse reactions", AJR Am J Roentgenol, 213, pp.1187~1193 (2019)
- Hong SJ, "Repid IV challenge", desensitization using iso-osmolar radiocontrast medium(RCM)in two patients at high risk for anaphylactoid reactions, 2002, pp.109, S150~
- Gandhi S, "Successful rapid intravenous desensitization for radioiodine contrast allergy in a patient requiring urgent coronary angiography", J Allergy Clin Immunol Pract, 2, pp.101~102 (2014)
- Jung JW, "Immediate hypersensitivity reaction to gadolinium-based MR contrast media", Radiology, 264, pp.414~422 (2012)
- Ahn YH, "Allergic-like hypersensitivity reactions to gadolinium-based contrast agents : an 8-year cohort study of 154 539 patients", Radiology, 303, pp.329~336 (2022)
- Lukawska J, "Anaphylaxis to trometamol excipient in gadolinium-based contrast agents for clinical imaging", J Allergy Clin Immunol Pract, 7, pp.1086~1087 (2019)
- Barbaud A, "Allergies and COVID-19 vaccines : an ENDA", EAACI position paper, 2022, pp.77, 2292~2312
- Grueber Hans-Peter, "Skin Test Results and Cross-Reactivity Patterns in IgE- and T-Cell-Mediated Allergy to Gadolinium-Based Contrast Agents", Allergy, Asthma & Immunology Research, 13(6), pp.933~938 (2021), 대한천식알레르기학회[DOI]
- Chiriac AM, "Clinical value of negative skin tests to gadolinium contrast agents", Allergy, 66, pp.1504~1506 (2011)